During the past decade, Vilnius University Children's Hospital conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 8 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 6 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vilnius University Children's Hospital" #1 sponsor was "Baxalta now part of Shire" with 2 trials, followed by "Eli Lilly and Company" with 2 trials sponsored, "Mats Heyman" with 2 trials sponsored, "AMAG Pharmaceuticals, Inc." with 1 trials sponsored and "Basilea Pharmaceutica" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vilnius University Children's Hospital" #1 collaborator was "Dermira, Inc." with 2 trials as a collaborator, "NordForsk" with 2 trials as a collaborator, "The Swedish Childhood Cancer Foundation" with 2 trials as a collaborator, "Aamu Pediatric Cancer Foundation" with 1 trials as a collaborator and "Acreditar - Associação de Pais e Amigos das Crianças com Cancro" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Vilnius University Children's Hospital" are "Atopic Dermatitis" (2 trials), "Chronic Kidney Disease" (2 trials), "Hemophilia A" (2 trials), "Leukemia, Acute Lymphoblastic" (2 trials) and "Acute Lymphoblastic Leukemia" (1 trials). Many other conditions were trialed in "Vilnius University Children's Hospital" in a lesser frequency.

Most popular intervention types in "Vilnius University Children's Hospital" are "Drug" (9 trials), "Biological" (4 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Lebrikizumab" (2 trials), "6-tioguanine+Standard Maintenance Therapy" (1 trials), "Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method" (1 trials) and "BAX855" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vilnius University Children's Hospital" are 14 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Vilnius University Children's Hospital". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Vilnius University Children's Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Vilnius University Children's Hospital, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".